ATLASLyell Immunopharma (LYEL) earnings date: Nov 11, 2026
Lyell Immunopharma (LYEL) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026. Analysts expect EPS of -$2.06.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on LYEL
| Last price | $10.88 (-1.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.6% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Lyell Immunopharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Lyell Immunopharma reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Lyell Immunopharma. You can switch it off at any time.
Alert me before LYEL reportsFree to start. Creating an account takes under a minute.
Notify me when Lyell Immunopharma reports
Track LYEL free Add Lyell Immunopharma to a free ATLAS watchlist and see its next report date in one place.
LYEL earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$2.06 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -36.4% |
| Average move around a report | ±8.0% (last 5) |
| Sector | Healthcare · Biotechnology |
Lyell Immunopharma earnings history: last 5 reports
Lyell Immunopharma last reported on Aug 6, 2026: EPS of -$1.74 against an estimate of -$1.79 (+2.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$1.79 | -$1.74 | +2.8% | Beat | +9.4% |
| Jun 23, 2026 | $0.76 | $0.74 | -2.6% | Miss | +8.6% |
| May 6, 2026 | -$2.36 | -$1.10 | +53.4% | Beat | -2.7% |
| Apr 14, 2026 | $0.44 | $0.48 | +9.1% | Beat | -3.9% |
| Mar 12, 2026 | -$2.23 | -$7.68 | -244.4% | Miss | -15.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for LYEL
See the fair value, the probability range and the earnings history of Lyell Immunopharma on its ATLAS page.
Lyell Immunopharma (LYEL) stock analysisPlans from €3.99 a month.
Lyell Immunopharma earnings: frequently asked questions
When does Lyell Immunopharma (LYEL) report earnings?
Lyell Immunopharma is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for LYEL?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$2.06 per share (USD). Estimates can change before the report.
How often does LYEL beat earnings estimates?
Of its last 5 reports with a recorded result, Lyell Immunopharma beat the EPS estimate 3 times; the average surprise was -36.4%. Past results do not predict the next one.
How much does LYEL move around earnings?
Over its last 5 reports the stock moved an average of 8.0% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Lyell Immunopharma beat earnings estimates last quarter?
Lyell Immunopharma last reported on Aug 6, 2026: EPS of -$1.74 against an estimate of -$1.79 (+2.8% surprise), a beat.
How much does LYEL usually move in a day?
On a normal trading day the ATLAS model puts LYEL’s one-day range at about ±4.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer